109 related articles for article (PubMed ID: 38761560)
1. Review of the comparative pathological and immunohistochemical features of human and canine cutaneous melanocytic neoplasms.
Contel IJ; Fonseca-Alves CE; Ferrari HF; Laufer-Amorim R; Xavier-Júnior JCC
J Comp Pathol; 2024 May; 211():26-35. PubMed ID: 38761560
[TBL] [Abstract][Full Text] [Related]
2. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis.
Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C
Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507
[TBL] [Abstract][Full Text] [Related]
3. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression.
Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C
Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968
[TBL] [Abstract][Full Text] [Related]
4. Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma.
Simpson RM; Bastian BC; Michael HT; Webster JD; Prasad ML; Conway CM; Prieto VM; Gary JM; Goldschmidt MH; Esplin DG; Smedley RC; Piris A; Meuten DJ; Kiupel M; Lee CC; Ward JM; Dwyer JE; Davis BJ; Anver MR; Molinolo AA; Hoover SB; Rodriguez-Canales J; Hewitt SM
Pigment Cell Melanoma Res; 2014 Jan; 27(1):37-47. PubMed ID: 24128326
[TBL] [Abstract][Full Text] [Related]
5. Canine melanocytes: Immunohistochemical expression of melanocytic markers in different somatic areas.
Porcellato I; Orlandi M; Lo Giudice A; Sforna M; Mechelli L; Brachelente C
Vet Dermatol; 2023 Aug; 34(4):284-297. PubMed ID: 36808650
[TBL] [Abstract][Full Text] [Related]
6. COX-1 and COX-2 expression in canine cutaneous, oral and ocular melanocytic tumours.
Pires I; Garcia A; Prada J; Queiroga FL
J Comp Pathol; 2010; 143(2-3):142-9. PubMed ID: 20207364
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between KIT Expression and
Smedley RC; Thaiwong T; Deeth LE; Kiupel M
Vet Pathol; 2021 Jul; 58(4):683-691. PubMed ID: 33910439
[No Abstract] [Full Text] [Related]
8. FoxP3 and IDO in Canine Melanocytic Tumors.
Porcellato I; Brachelente C; De Paolis L; Menchetti L; Silvestri S; Sforna M; Vichi G; Iussich S; Mechelli L
Vet Pathol; 2019 Mar; 56(2):189-199. PubMed ID: 30381008
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical investigation of PNL2 reactivity of canine melanocytic neoplasms and comparison with Melan A.
Giudice C; Ceciliani F; Rondena M; Stefanello D; Grieco V
J Vet Diagn Invest; 2010 May; 22(3):389-94. PubMed ID: 20453212
[TBL] [Abstract][Full Text] [Related]
10. Canine melanoma diagnosis: RACK1 as a potential biological marker.
Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618
[TBL] [Abstract][Full Text] [Related]
11. C-kit expression in canine mucosal melanomas.
Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
[TBL] [Abstract][Full Text] [Related]
12. Congenital cutaneous melanoma in a dog.
Meyrer B; Bianchi SP; Pavarini SP; Gerardi DG
Vet Dermatol; 2017 Apr; 28(2):228-e56. PubMed ID: 27813258
[TBL] [Abstract][Full Text] [Related]
13. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas.
Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E
Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423
[TBL] [Abstract][Full Text] [Related]
14. Mast cells and angiogenesis in canine melanomas: malignancy and clinicopathological factors.
Mukaratirwa S; Chikafa L; Dliwayo R; Moyo N
Vet Dermatol; 2006 Apr; 17(2):141-6. PubMed ID: 16515657
[TBL] [Abstract][Full Text] [Related]
15. Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.
Millanta F; Fratini F; Corazza M; Castagnaro M; Zappulli V; Poli A
Res Vet Sci; 2002 Aug; 73(1):45-51. PubMed ID: 12208106
[TBL] [Abstract][Full Text] [Related]
16. Immunoexpression of S100A4 in canine skin melanomas and correlation with histopathological parameters.
Grandi F; Rocha RM; Miot HA; Cogliati B; Rocha NS
Vet Q; 2014; 34(2):98-104. PubMed ID: 25023931
[TBL] [Abstract][Full Text] [Related]
17. PCNA and Ki67 proliferation markers as criteria for prediction of clinical behaviour of melanocytic tumours in cats and dogs.
Roels S; Tilmant K; Ducatelle R
J Comp Pathol; 1999 Jul; 121(1):13-24. PubMed ID: 10373290
[TBL] [Abstract][Full Text] [Related]
18. Canine Melanomas as Models for Human Melanomas: Clinical, Histological, and Genetic Comparison.
Prouteau A; André C
Genes (Basel); 2019 Jun; 10(7):. PubMed ID: 31262050
[TBL] [Abstract][Full Text] [Related]
19. Lack of prognostic significance of angiogenesis in canine melanocytic tumours.
Cuitiño MC; Massone AR; Idiart JR
J Comp Pathol; 2012; 147(2-3):147-52. PubMed ID: 22520819
[TBL] [Abstract][Full Text] [Related]
20. Comparative aspects of cutaneous melanocytic neoplasms in the dog.
Dunstan RW; Rosser EJ
Am J Dermatopathol; 1985; 7 Suppl():197-201. PubMed ID: 3940086
[No Abstract] [Full Text] [Related]
[Next] [New Search]
